Contents
Current Neuropharmacology, Volume 13 - Number 5
Editorial
Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders)
, 13(5): 556 - 557Andre F. Carvalho and Roger S. McIntyre
DOI: 10.2174/1570159X1305151013195022
The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
, 13(5): 558 - 576Beatrice Bortolato, Andre F. Carvalho, Joanna K. Soczynska, Giulia I. Perini and Roger S. McIntyre
DOI: 10.2174/1570159X13666150630171433
The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
Treatment-resistant Late-life Depression: Challenges and Perspectives
, 13(5): 577 - 591Christian Knochel, Gilberto Alves, Benedikt Friedrichs, Barbara Schneider, Anna Schmidt-Rechau, Sofia Wenzler, Angelina Schneider, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel
DOI: 10.2174/1570159X1305151013200032
Treatment-resistant Late-life Depression: Challenges and Perspectives
Pharmacological Approaches for Treatment-resistant Bipolar Disorder
, 13(5): 592 - 604Shi Hui Poon, Kang Sim and Ross J. Baldessarini
DOI: 10.2174/1570159X13666150630171954
Pharmacological Approaches for Treatment-resistant Bipolar Disorder
From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
, 13(5): 605 - 615Konstantinos N. Fountoulakis, Roger S. McIntyre and Andre F. Carvalho
DOI: 10.2174/1570159X13666150630174343
From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
, 13(5): 616 - 635Rafael T. de Sousa, Marcus V. Zanetti, Andre R. Brunoni and Rodrigo Machado-Vieira
DOI: 10.2174/1570159X13666150630173522
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
, 13(5): 636 - 655Joshua D. Rosenblat, Roger S. McIntyre, Gilberto S. Alves, Konstantinos N. Fountoulakis and Andre F. Carvalho
DOI: 10.2174/1570159X13666150630175044
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
, 13(5): 656 - 662Seetal Dodd, Brisa S. Fernandes and Olivia M. Dean
DOI: 10.2174/1570159X13666150630175841
Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
, 13(5): 663 - 680Christian Knochel, Martin Voss, Florian Gruter, Gilberto S. Alves, Silke Matura, Beate Sepanski, Michael Stablein, Sofia Wenzler, David Prvulovic, Andre F. Carvalho and Viola Oertel-Knochel
DOI: 10.2174/1570159X13666150630173047
Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
, 13(5): 681 - 691Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington
DOI: 10.2174/1570159X13666150115220221
The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
The Management and Outcomes of Pharmacological Treatments for Tinnitus
, 13(5): 692 - 700Devon Beebe Palumbo, Kathleen Joos, Dirk De Ridder and Sven Vanneste
DOI: 10.2174/1570159X13666150415002743
Myalgic Encephalomyelitis: Symptoms and Biomarkers
, 13(5): 701 - 734Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn
DOI: 10.2174/1570159X13666150928105725
Myalgic Encephalomyelitis: Symptoms and Biomarkers
Webmaster Contact: info@benthamscience.org